Suvorexant tablets, over-encapsulated: Clinical Trials

1 trial of Suvorexant tablets, over-encapsulated, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Suvorexant tablets, over-encapsulated: new trials by email Literature Review of Suvorexant tablets, over-encapsulated trials Research Report on Suvorexant tablets, over-encapsulated

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users
Zolpidem tablets, Suvorexant tablets, over-encapsulated, Lemborexant tablets - Insomnia Disorders
Phase 1CompletedEisai Inc.392017-04-192020-06-29

Conditions studied

Sleep Initiation and Maintenance Disorders (1)

Sponsors

Eisai Inc. (1)

Countries

Canada (1)

Results publications

PMID 35748777